Mild to Moderate Hepatic Impairment Has No Effect on the Single Dose Pharmacokinetics of Alisporivir (ALV)

被引：0
|
作者：
Kovacs, Steven J.
Ke, June
Praestgaard, Jens
Barve, Avantika
Zhang, Jie
Maietta, Robert
Sunkara, Gangadhar
Stein, Daniel S.
机构：
来源：
GASTROENTEROLOGY | 2013年 / 144卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：S977 / S977
页数：1
相关论文
共 50 条
  • [41] Lack of Effect of Moderate Hepatic Impairment on the Pharmacokinetics of Telavancin
    Goldberg, Michael R.
    Wong, Shekman L.
    Shaw, Jeng-Pyng
    Kitt, Michael M.
    Barriere, Steven L.
    PHARMACOTHERAPY, 2010, 30 (01): : 35 - 42
  • [42] The Effect of Mild and Moderate Hepatic Impairment on the Pharmacokinetics of Tofacitinib, an Orally Active Janus Kinase Inhibitor
    Lawendy, Nervin
    Lamba, Manisha
    Chan, Gary
    Wang, Rong
    Alvey, Christine W.
    Krishnaswami, Sriram
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2014, 3 (06): : 421 - 427
  • [43] The effect of mild and moderate hepatic impairment on the pharmacokinetics of valdecoxib, a selective COX-2 inhibitor
    Nenad Sarapa
    Margaret R. Britto
    Michelle B. Mainka
    Kourosh Parivar
    European Journal of Clinical Pharmacology, 2005, 61 : 247 - 256
  • [44] The effect of mild and moderate hepatic impairment on the pharmacokinetics of valdecoxib, a selective COX-2 inhibitor
    Sarapa, N
    Britto, MR
    Mainka, MB
    Parivar, K
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 61 (04) : 247 - 256
  • [45] EFFECT OF MODERATE OR SEVERE HEPATIC IMPAIRMENT ON CLARITHROMYCIN PHARMACOKINETICS
    CHU, SY
    GRANNEMAN, GR
    PICHOTTA, PJ
    DECOURT, JP
    GIRAULT, J
    FOURTILLAN, JB
    JOURNAL OF CLINICAL PHARMACOLOGY, 1993, 33 (05): : 480 - 485
  • [46] EFFECT OF MODERATE HEPATIC IMPAIRMENT ON THE SAFETY AND PHARMACOKINETICS OF REZAFUNGIN
    Ong, Voon
    Sandison, Taylor
    Melara, Rebeca
    Marbury, Thomas
    Huguet, Jade
    Jandourek, Alena
    Flanagan, Shawn
    CRITICAL CARE MEDICINE, 2021, 49 (01) : 334 - 334
  • [47] Pharmacokinetics, Safety, and Tolerability of Tanimilast Following Single Administrations in Subjects With Mild, Moderate, and Severe Hepatic Impairment
    Emirova, A.
    Piccino, A.
    Rizzo, E.
    Pittelli, M.
    Bellatti, P.
    Rostello, C.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
  • [48] Pharmacokinetics of Multiple-Dose Darunavir in Combination with Low-Dose Ritonavir in Individuals with Mild-to-Moderate Hepatic Impairment
    Sekar, Vanitha
    Spinosa-Guzman, Sabrina
    De Paepe, Els
    Stevens, Tanja
    Tomaka, Frank
    De Pauw, Martine
    Hoetelmans, Richard M. W.
    CLINICAL PHARMACOKINETICS, 2010, 49 (05) : 343 - 350
  • [49] Pharmacokinetics of Multiple-Dose Darunavir in Combination with Low-Dose Ritonavir in Individuals with Mild-to-Moderate Hepatic Impairment
    Vanitha Sekar
    Sabrina Spinosa-Guzman
    Els De Paepe
    Tanja Stevens
    Frank Tomaka
    Martine De Pauw
    Richard M. W. Hoetelmans
    Clinical Pharmacokinetics, 2010, 49 : 343 - 350
  • [50] Open-label, Single-dose Studies of the Pharmacokinetics of Edaravone in Subjects with Mild, Moderate, or Severe Hepatic Impairment Compared to Subjects with Normal Hepatic Functioning
    Nakamaru, Yoshinobu
    Kakubari, Masae
    Yoshida, Kaori
    Akimoto, Makoto
    Todorovic, Vesna
    Greis, Thomas
    Kondo, Kazuoki
    CLINICAL THERAPEUTICS, 2020, 42 (08) : 1467 - +
12345